{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:01:42Z","timestamp":1789981302663,"version":"4.0.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004763","name":"Natural Science Foundation of Inner Mongolia Autonomous Region","doi-asserted-by":"publisher","award":["2021MS08010"],"award-info":[{"award-number":["2021MS08010"]}],"id":[{"id":"10.13039\/501100004763","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00210-026-05577-2","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:15:59Z","timestamp":1782180959000},"page":"19309-19327","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From network prediction to in vivo validation: luteolin attenuates cholestatic liver injury in association with PI3K\/Akt\/GSK-3\u03b2 signalling modulation"],"prefix":"10.1007","volume":"399","author":[{"given":"Yuxin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiji","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"5577_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29051093","author":"SA Almatroodi","year":"2024","unstructured":"Almatroodi SA, Almatroudi A, Alharbi HOA, Khan AA, Rahmani AH (2024) Effects and mechanisms of luteolin, a plant-based flavonoid, in the prevention of cancers via modulation of inflammation and cell signaling molecules. MDPI AG. https:\/\/doi.org\/10.3390\/molecules29051093","journal-title":"MDPI AG"},{"key":"5577_CR2","doi-asserted-by":"publisher","unstructured":"Aseem SO, Wang J, Kalaiger MF, Way G, Zhao D, Tai Y, \u2026 Zhou H (2025) Aramchol attenuates fibrosis in mouse models of biliary fibrosis and blocks the TGF\u03b2-induced fibroinflammatory mediators in cholangiocytes. Ovid Technol (Wolters Kluwer Health). https:\/\/doi.org\/10.1097\/hc9.0000000000000748","DOI":"10.1097\/hc9.0000000000000748"},{"key":"5577_CR3","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-5110","author":"SY Cai","year":"2021","unstructured":"Cai SY, Boyer JL (2021) The role of bile acids in cholestatic liver injury. Ann Transl Med. https:\/\/doi.org\/10.21037\/atm-20-5110","journal-title":"Ann Transl Med"},{"key":"5577_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29289","author":"JYL Chiang","year":"2017","unstructured":"Chiang JYL (2017) Linking long noncoding RNA to control bile acid signaling and cholestatic liver fibrosis. Ovid Technol (Wolters Kluwer Health). https:\/\/doi.org\/10.1002\/hep.29289","journal-title":"Ovid Technol (Wolters Kluwer Health)"},{"key":"5577_CR5","doi-asserted-by":"publisher","unstructured":"Ding X, Zhu XL, Xu DH, Li S, Yang Q, Feng X, \u2026 Shi SL (2023) NPM promotes hepatotoxin-induced fibrosis by inhibiting ROS-induced apoptosis of hepatic stellate cells and upregulating lncMIAT-induced TGF-\u03b22. Springer Science and Business Media LLC. https:\/\/doi.org\/10.1038\/s41419-023-06043-0","DOI":"10.1038\/s41419-023-06043-0"},{"key":"5577_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/s1665-2681(19)31792-2","author":"GA El-Sherbiny","year":"2009","unstructured":"El-Sherbiny GA, Taye A, Abdel-Raheem IT (2009) Role of ursodeoxycholic acid in prevention of hepatotoxicity caused by amoxicillin-clavulanic acid in rats. Ann Hepatol. https:\/\/doi.org\/10.1016\/s1665-2681(19)31792-2","journal-title":"Ann Hepatol"},{"key":"5577_CR7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.reth.2025.09.008","volume":"30","author":"Y Gao","year":"2025","unstructured":"Gao Y, Chen Y, Mang Y, Zhang X, Li X, Zhang S (2025) Cholangiocyte-derived exosomal miR-381-3p promotes hepatic stellate cell activation and cholestatic liver fibrosis via targeting Klf6. Regen Ther 30:769\u2013777. https:\/\/doi.org\/10.1016\/j.reth.2025.09.008","journal-title":"Regen Ther"},{"key":"5577_CR8","doi-asserted-by":"publisher","unstructured":"Gottlieb SS, Harris K, Todd J, Estis J, Christenson RH, Torres V, \u2026 Krantz DS (2015) Prognostic significance of active and modified forms of endothelin 1 in patients with heart failure with reduced ejection fraction. Elsevier BV. https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.12.012","DOI":"10.1016\/j.clinbiochem.2014.12.012"},{"key":"5577_CR9","doi-asserted-by":"publisher","unstructured":"Guo J, Jiang X, Lian J, Li H, Zhang F, Xie J, \u2026 Hao E (2024) Evaluation of the effect of GSK-3\u03b2 on liver cancer based on the PI3K\/AKT pathway. Front Media SA. https:\/\/doi.org\/10.3389\/fcell.2024.1431423","DOI":"10.3389\/fcell.2024.1431423"},{"key":"5577_CR10","doi-asserted-by":"publisher","unstructured":"Holtmann TM, Inzaugarat ME, Knorr J, Geisler L, Schulz M, Bieghs V, \u2026 Wree A (2021) Bile acids activate NLRP3 inflammasome, promoting murine liver inflammation or fibrosis in a cell type-specific manner. MDPI AG. https:\/\/doi.org\/10.3390\/cells10102618","DOI":"10.3390\/cells10102618"},{"key":"5577_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2008.08.079","author":"R Ilouz","year":"2008","unstructured":"Ilouz R, Pietrokovski S, Eisenstein M, Eldar-Finkelman H (2008) New insights into the autoinhibition mechanism of glycogen synthase kinase-3\u03b2. J Mol Biol. https:\/\/doi.org\/10.1016\/j.jmb.2008.08.079","journal-title":"J Mol Biol"},{"key":"5577_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11081437","author":"E Jang","year":"2022","unstructured":"Jang E (2022) Hyperoside as a potential natural product targeting oxidative stress in liver diseases. MDPI AG. https:\/\/doi.org\/10.3390\/antiox11081437","journal-title":"MDPI AG"},{"key":"5577_CR13","doi-asserted-by":"publisher","unstructured":"Kolari\u0107 TO, Nin\u010devi\u0107 V, Smoli\u0107 R, Smoli\u0107 M, Wu GY (2019) Mechanisms of hepatic cholestatic drug injury. J Clin Transl Hepatol. https:\/\/doi.org\/10.14218\/jcth.2018.00042","DOI":"10.14218\/jcth.2018.00042"},{"key":"5577_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00149","author":"A Kriegermeier","year":"2020","unstructured":"Kriegermeier A, Green R (2020) Pediatric cholestatic liver disease: review of bile acid metabolism and discussion of current and emerging therapies. Front Media SA. https:\/\/doi.org\/10.3389\/fmed.2020.00149","journal-title":"Front Media SA"},{"key":"5577_CR15","doi-asserted-by":"publisher","unstructured":"Li J, Li X, Xu W, Wang S, Hu Z, Zhang Q, \u2026 Guo C (2014) Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT\/mTOR\/p70S6K and TGF\u03b2\/Smad signalling pathways. Wiley. https:\/\/doi.org\/10.1111\/liv.12638","DOI":"10.1111\/liv.12638"},{"key":"5577_CR16","doi-asserted-by":"publisher","unstructured":"Li X, Liu R, Wang Y, Zhu W, Zhao D, Wang X, \u2026 Zhou H (2020) Cholangiocyte-derived exosomal lncRNA H19 promotes macrophage activation and hepatic inflammation under cholestatic conditions. MDPI AG. https:\/\/doi.org\/10.3390\/cells9010190","DOI":"10.3390\/cells9010190"},{"issue":"1","key":"5577_CR17","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1038\/s42003-024-07192-4","volume":"7","author":"J Li","year":"2024","unstructured":"Li J, Yao S, Zimny S, Koob D, Jin H, Wimmer R, Hohenester S (2024) The acidic microenvironment in the perisinusoidal space critically determines bile salt-induced activation of hepatic stellate cells. Commun Biol 7(1):1591. https:\/\/doi.org\/10.1038\/s42003-024-07192-4","journal-title":"Commun Biol"},{"key":"5577_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1485065","author":"Y Liao","year":"2024","unstructured":"Liao Y, Lv F, Quan T, Wang C, Li J (2024) Flavonoids in natural products for the therapy of liver diseases: progress and future opportunities. Front Media SA. https:\/\/doi.org\/10.3389\/fphar.2024.1485065","journal-title":"Front Media SA"},{"key":"5577_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/genes13122201","author":"X Liu","year":"2022","unstructured":"Liu X, Ma H, Wu R, Wang H, Xu H, Li S, Wang G, Niu J (2022) Identification of liver fibrosis-related micrornas in human primary hepatic stellate cells using high-throughput sequencing. Genes (Basel). https:\/\/doi.org\/10.3390\/genes13122201","journal-title":"Genes (Basel)"},{"key":"5577_CR20","doi-asserted-by":"publisher","unstructured":"Lu L (2022) Guidelines for the management of cholestatic liver diseases (2021). Xia & He Publishing. https:\/\/doi.org\/10.14218\/jcth.2022.00147","DOI":"10.14218\/jcth.2022.00147"},{"key":"5577_CR21","doi-asserted-by":"publisher","unstructured":"Majeed Y, Upadhyay R, Alhousseiny S, Taha T, Musthak A, Shaheen Y, \u2026 Ding H (2019) Potent and PPAR\u03b1-independent anti-proliferative action of the hypolipidemic drug fenofibrate in VEGF-dependent angiosarcomas in vitro. Springer Science and Business Media LLC. https:\/\/doi.org\/10.1038\/s41598-019-42838-y","DOI":"10.1038\/s41598-019-42838-y"},{"key":"5577_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10081763","author":"M Mazzetti","year":"2021","unstructured":"Mazzetti M, Marconi G, Mancinelli M, Benedetti A, Marzioni M, Maroni L (2021) The management of cholestatic liver diseases: current therapies and emerging new possibilities. MDPI AG. https:\/\/doi.org\/10.3390\/jcm10081763","journal-title":"MDPI AG"},{"key":"5577_CR23","doi-asserted-by":"publisher","unstructured":"Pan X, Ma X, Jiang Y, Wen J, Yang L, Chen D, \u2026 Peng C (2020) A comprehensive review of natural products against liver fibrosis: flavonoids, quinones, lignans, phenols, and acids. Wiley. https:\/\/doi.org\/10.1155\/2020\/7171498","DOI":"10.1155\/2020\/7171498"},{"issue":"1","key":"5577_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s10020-025-01153-1","volume":"31","author":"X Qin","year":"2025","unstructured":"Qin X, Hu D, Li Q, Zhang S, Qin Z, Wang L, Liu Y (2025) LXR\u03b1 agonists ameliorates acute rejection after liver transplantation via ABCA1\/MAPK and PI3K\/AKT\/mTOR signaling axis in macrophages. Mol Med 31(1):99. https:\/\/doi.org\/10.1186\/s10020-025-01153-1","journal-title":"Mol Med"},{"key":"5577_CR25","doi-asserted-by":"publisher","DOI":"10.1177\/1756284818787400","author":"P Santiago","year":"2018","unstructured":"Santiago P, Scheinberg AR, Levy C (2018) Cholestatic liver diseases: new targets, new therapies. SAGE Publications. https:\/\/doi.org\/10.1177\/1756284818787400","journal-title":"SAGE Publications"},{"issue":"9","key":"5577_CR26","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.1002\/ptr.7871","volume":"37","author":"JH Seo","year":"2023","unstructured":"Seo JH, Lee HJ, Sim DY, Park JE, Ahn CH, Park SY, Lee H\u2010J, Ahn C\u2010H, Park S\u2010Y, Kim B, Kim S\u2010H, Kim SH (2023) Honokiol inhibits epithelial-mesenchymal transition and hepatic fibrosis via activation of Ecadherin\/GSK3\u03b2\/JNK and inhibition of AKT\/ERK\/p38\/\u03b2-catenin\/TMPRSS4 signaling axis. Phytother Res 37(9):4092\u20134101. https:\/\/doi.org\/10.1002\/ptr.7871","journal-title":"Phytother Res"},{"key":"5577_CR27","doi-asserted-by":"publisher","unstructured":"Shearn CT, Anderson AL, Miller CG, Noyd RC, Devereaux MW, Balasubramaniyan N, \u2026 Sokol RJ (2023) Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injury. Ovid Technol (Wolters Kluwer Health). https:\/\/doi.org\/10.1097\/hc9.0000000000000020","DOI":"10.1097\/hc9.0000000000000020"},{"issue":"8","key":"5577_CR28","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.3390\/ijms26083804","volume":"26","author":"P Taweesap","year":"2025","unstructured":"Taweesap P, Potue P, Khamseekaew J, Iampanichakul M, Jan-O B, Pakdeechote P, Maneesai P (2025) Luteolin relieves metabolic dysfunction-associated fatty liver disease caused by a high-fat diet in rats through modulating the AdipoR1\/AMPK\/PPAR\u03b3 signaling pathway. Int J Mol Sci 26(8):3804. https:\/\/doi.org\/10.3390\/ijms26083804","journal-title":"Int J Mol Sci"},{"key":"5577_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21334","author":"O Trott","year":"2009","unstructured":"Trott O, Olson AJ (2009) AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Wiley. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"Wiley"},{"key":"5577_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2019.105422","author":"V Vilas-Boas","year":"2020","unstructured":"Vilas-Boas V, Gijbels E, Jonckheer J, De Waele E, Vinken M (2020) Cholestatic liver injury induced by food additives, dietary supplements and parenteral nutrition. Elsevier BV. https:\/\/doi.org\/10.1016\/j.envint.2019.105422","journal-title":"Elsevier BV"},{"key":"5577_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1396023","author":"X Wang","year":"2024","unstructured":"Wang X, Cao S, Huang Y, Li L, Xu D, Liu L (2024) Salidroside alleviates cholestasis-induced liver fibrosis by inhibiting hepatic stellate cells via activation of the PI3K\/AKT\/GSK-3\u03b2 signaling pathway and regulating intestinal flora distribution. Frontiers Media SA. https:\/\/doi.org\/10.3389\/fphar.2024.1396023","journal-title":"Frontiers Media SA"},{"key":"5577_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28145504","author":"Y Wang","year":"2023","unstructured":"Wang Y, Shi K, Tu J, Ke C, Chen N, Wang B, Zhou Z (2023) Atractylenolide III ameliorates bile duct ligation-induced liver fibrosis by inhibiting the PI3K\/AKT pathway and regulating glutamine metabolism. Molecules. https:\/\/doi.org\/10.3390\/molecules28145504","journal-title":"Molecules"},{"key":"5577_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051107","author":"H Wu","year":"2021","unstructured":"Wu H, Chen C, Ziani S, Nelson LJ, \u00c1vila MA, Nevzorova YA, Cubero FJ (2021) Fibrotic events in the progression of cholestatic liver disease. MDPI AG. https:\/\/doi.org\/10.3390\/cells10051107","journal-title":"MDPI AG"},{"key":"5577_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2014.01.003","author":"Y Xiao","year":"2014","unstructured":"Xiao Y, Wang J, Chen Y, Zhou K, Wen J, Wang Y, Zhou Y, Cai W (2014) Up-regulation of miR-200b in biliary atresia patients accelerates proliferation and migration of hepatic stallate cells by activating PI3K\/Akt signaling. Cell Signal. https:\/\/doi.org\/10.1016\/j.cellsig.2014.01.003","journal-title":"Cell Signal"},{"key":"5577_CR35","doi-asserted-by":"publisher","unstructured":"Xie L, Chen H, Zhang L, Ma Y, Zhou Y, Yang YY, \u2026 Wu J (2024) JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis. Clin Mol Hepatol 30(2):206\u2013224. https:\/\/doi.org\/10.3350\/cmh.2023.0506","DOI":"10.3350\/cmh.2023.0506"},{"key":"5577_CR36","doi-asserted-by":"publisher","unstructured":"Xu Z, Li T, Li M, Yang L, Xiao R, Liu L, \u2026 Liu D (2018) eRF3b-37 inhibits the TGF-\u03b21-induced activation of hepatic stellate cells by regulating cell proliferation, G0\/G1 arrest, apoptosis and migration. Spandidos Publications. https:\/\/doi.org\/10.3892\/ijmm.2018.3900","DOI":"10.3892\/ijmm.2018.3900"},{"key":"5577_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/srep37157","author":"D Yang","year":"2016","unstructured":"Yang D, Tan X, Lv Z, Liu B, Baiyun R, Lu J, Zhang Z (2016) Regulation of Sirt1\/Nrf2\/TNF-\u03b1 signaling pathway by luteolin is critical to attenuate acute mercuric chloride exposure induced hepatotoxicity. Springer Sci Busi Media LLC. https:\/\/doi.org\/10.1038\/srep37157","journal-title":"Springer Sci Busi Media LLC"},{"issue":"2","key":"5577_CR38","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3350\/cmh.2022.0327","volume":"29","author":"J Yang","year":"2023","unstructured":"Yang J, Tang X, Liang Z, Chen M, Sun L (2023) Taurocholic acid promotes hepatic stellate cell activation via S1PR2\/p38 MAPK\/YAP signaling under cholestatic conditions. Clin Mol Hepatol 29(2):465\u2013481. https:\/\/doi.org\/10.3350\/cmh.2022.0327","journal-title":"Clin Mol Hepatol"},{"key":"5577_CR39","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v15.i2.180","author":"CY Zhang","year":"2023","unstructured":"Zhang CY, Liu S, Yang M (2023) Antioxidant and anti-inflammatory agents in chronic liver diseases: molecular mechanisms and therapy. World J Hepatol. https:\/\/doi.org\/10.4254\/wjh.v15.i2.180","journal-title":"World J Hepatol"},{"key":"5577_CR40","doi-asserted-by":"publisher","unstructured":"Zhou H, Yu Y, Zhang J, Zhang Y, Luan Q, Wang G (2018) Protective effects the Akt activator SC79 in hepatic ischemia-reperfusion injury. Int Sci Inf, Inc. https:\/\/doi.org\/10.12659\/msm.911178","DOI":"10.12659\/msm.911178"},{"key":"5577_CR41","doi-asserted-by":"publisher","unstructured":"Zimny S, Koob D, Li J, Wimmer R, Schiergens T, Nagel J, \u2026 Hohenester S (2022) Hydrophobic bile salts induce pro-fibrogenic proliferation of hepatic stellate cells through PI3K p110 Alpha Signaling. MDPI AG. https:\/\/doi.org\/10.3390\/cells11152344","DOI":"10.3390\/cells11152344"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05577-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05577-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05577-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:13:37Z","timestamp":1789978417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05577-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5577"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05577-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Animal Ethics Committee of Baotou Central Hospital (Approval Number: 2022\u201360). All animal procedures were conducted in accordance with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health, NIH) and the Animal Research: Reporting of In Vivo Experiments (ARRIVE) 2.0 guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}